Oncology Companion Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

Oncology Companion Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : May, 2021 | Medical Devices

Report Digest

Global Oncology Companion Diagnostic Market: Overview

Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients. It is these characteristics that determine who are non-responders and who are the responders to the therapy. The development of the global oncology companion diagnostic market is likely to be driven by the evolution and progress made in the cancer treatment sector. The US-based food and drug administration (FDA) has already given approval for single-agent regimens and ten new combinations, which are being utilized with a certain CDx assay from the beginning of January 2020.

The major players in the global oncology companion diagnostic market are constantly focusing on new product launches and approvals in this market space. This factor is likely to drive the demand for oncology companion diagnostic in the years to come. Immunohistochemistry (IHC) – based CDx assists in the process of rapid drug development and often results in successful approvals.

Product and service, technology, disease type, and region are the four key parameters based on which the global oncology companion diagnostic market has been divided. The objective of such segmentation is to offer a clearer, 360-degree view of the market.

Global Oncology Companion Diagnostic Market: Notable Developments

The global oncology companion diagnostic market has witnessed significant developments in the recent years. One of such developments pertaining to the market is mentioned below:

  • In July 2020, the FDA gave nod to Ventana HER2 Dual ISH DNA Probe Cocktail assay. This newly approved assay is expected to work as a fast and novel method to be used for the detection of HER2 biomarker for breast cancer. This assay is also anticipated to work in the form of companion diagnostic for Herceptin therapy.

Some of the key players in the global oncology companion diagnostic market comprise the below-mentioned:

  • Thermo Fisher Scientific, Inc
  • Myriad Genetics, Inc
  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Associated Regional and University Pathologists (ARUP), Inc

Global Oncology Companion Diagnostic Market: Key Trends

The following drivers, restraints, and opportunities characterize global oncology companion diagnostic market over the assessment period, from 2019 to 2027.

Economic Benefits Offered by the Assay to Shoot Up its Demand in the Market

The growth of the global oncology companion diagnostic market is primarily driven by the economic benefits offered by oncology companion diagnostics assays or (CDx). In addition to that, these assays are able to lessen the time taken by clinical trial, which has played an important role in augmenting its uptake by the pharmaceutical manufacturing companies. Companion diagnostics are capable of improving the effects of treatment of various diseases by offering clinicians a crystal clear clinical ground for treatment and diagnosis.  In addition to that, it also helps in managing national insurance policies and patient resources more efficiently through reduction of unnecessary treatment with costly drugs of chemotherapy. This cost effective aspect is likely to foster growth of the global oncology companion diagnostic market over the period of analysis, form 2019 to 2027.

Global Oncology Companion Diagnostic Market: Geographical Analysis

North America is anticipated to exert dominance over the global oncology companion diagnostic market and the trend is likely to continue throughout the tenure of assessment. The region is estimated to account for a large chunk of the total market revenue. Such growth of the North America market is ascribed to the increased grants and funding given by bodies like National Cancer Institute (NCI) so as to speed up the development of precision therapy.

The global oncology companion diagnostic market is segmented as:

Product and Service

  • Instrument
  • Consumables
  • Software
  • Service


  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC)
  • In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

Disease Type

  • Breast Cancer
  • Non-Small Cell Lung Cancer
  • Colorectal Cancer
  • Leukemia
  • Melanoma
  • Prostate Cancer


  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
  • Asia Pacific
    • China
    • Japan
    • Korea
    • India
    • Southeast Asia
  • The Middle East
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
  • Latin America
    • Brazil
    • Argentina
    • Colombia

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?